Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin augmentation in recent-onset psychotic disorder
NL-OMON47934Phase 3Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia, schizophreniform disorder, schizoaffective disorder and 1 more comparing Simvastatin augmentation with Placebo augmentation (2 arms). Primary endpoints: Change in total symptom severity and Neurocognitive functioning. Started Nov 2013; status: active, not recruiting.
02
Drugs
simvastatin
03
Conditions
schizophreniaschizophreniform disorderschizoaffective disorderSchizophrenia Spectrum Disorders (SSD)
Beyond the preview
Go deeper on NL-OMON47934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47934.